This site is intended for healthcare professionals only
LoginRegister
NPPA Panel Defers Biological Es Pneumonia Vaccine Price Exemption, Seeks ClarificationBiological E Gets CDSCO Panel Nod To Study Inactivated Poliomyelitis Vaccine
Drug alert: CDSCO flags 60 formulations as not of standard qualityHealth Ministry Invites Application For Deputy Director at CDSCO's CDTL Mumbai, Salary Up to Rs 2.09...
CDSCO Panel Approves GSKs Proposal to Double Indian Patient Pool in Dostarlimab TrialGSK Pharma's Q3 Profit Jumps 35% on Strong Demand for Augmentin, Respiratory Drugs
USFDA issues EIR for Cohance Lifesciences Telangana facilitySurprise Inspection of Pharma Firms in Baddi Amid Counterfeit Drug Concerns
Modernas Q4 Revenue Falls 66% to USD 966M Amid COVID Vaccine Sales SlumpModerna's Q4 Revenue Falls 66% to USD 966M Amid COVID Vaccine Sales Slump
West Pharmas 2025 Forecast Misses Estimates as Inventory Reductions ContinueWest Pharma's 2025 Forecast Misses Estimates as Inventory Reductions Continue
CDSCO Panel Approves BE Study for Alkems Dapagliflozin, Pioglitazone, Metformin FDC, Seeks Revised Phase III PlanRetinal examination be done at each visit: CDSCO Panel tells Alkem Lab on Semaglutide Injection...
Shilpa Medicare Dabaspet unit gets VAI classification from USFDAZydus' Ambernath API Plant Clears USFDA Inspection with Zero Observations
Investigation Lapses Lead to Acquittal in Hospital Voyeurism CaseCourt Relief: Pharma MD Gets Bail After 22-Month Jail In Tramadol Smuggling Case
CDSCO Panel Accepts Glenmarks Apremilast Trial Report, Seeks 2-Year PSUR DataUS Market Pressure Weighs on Glenmark's Q3 Earnings, Profit Below Estimates
Setback for Moderna: USFDA Halts Norovirus Vaccine Trial After Guillain-Barre Syndrome CaseSetback for Moderna: USFDA Halts Norovirus Vaccine Trial After Guillain-Barre Syndrome Case
Roche Susvimo maintains vision over five years with two refills per year in people with nAMDUSFDA Approves Roche's Evrysdi Tablet for Spinal Muscular Atrophy
X